Boost Your Immunity: Can Vitamins A & C Really Help with HIV and TB?
"New study examines whether Vitamin A and C supplementation can modulate oxidative stress in HIV and HIV-TB co-infected patients, revealing surprising results."
HIV and tuberculosis (TB) infections often lead to increased oxidative stress, potentially weakening the body's defense systems. This has led to the exploration of antioxidant supplements, like vitamins A and C, as potential support for individuals battling these infections. While the idea of boosting the immune system with these vitamins is appealing, research findings have been mixed.
A new study conducted at Lagos University Teaching Hospital (LUTH) in Nigeria, investigated the impact of vitamin A and C supplementation on oxidative stress levels in people living with HIV, and those co-infected with HIV and TB. The goal was to determine if these readily available vitamins could offer a tangible benefit in managing the challenges posed by these infections.
This article breaks down the study's findings, explaining what oxidative stress is, how HIV and TB affect it, and what the research reveals about the effectiveness of vitamin A and C supplementation. We'll explore whether these supplements live up to the hype and what the implications are for individuals seeking to support their health during HIV and/or TB treatment.
Oxidative Stress During HIV Treatment
Oxidative stress is an imbalance in which oxidant molecules outweigh antioxidants, and it has been associated with increased morbidity and mortality among people with HIV receiving antiretroviral therapy (ART). A 2025 review reports higher oxidative stress without changes in antioxidant levels among HIV-positive smokers and people with substance abuse. It also reports that long-term ART use was associated with higher oxidative protein products and lower antioxidant levels than short-term use. The review describes supplements from diverse sources as possible interventions under investigation, rather than establishing them as a proven solution.
ROS and HIV-Associated TB
Reactive oxygen species (ROS) serve as signaling molecules in normal cellular processes, but excess ROS can lead to oxidative stress. A 2024 review describes oxidative stress as playing a critical role in HIV pathogenesis and being associated with comorbidities in people with HIV. It also reports that oxidative stress linked to HIV may worsen HIV-associated tuberculosis by promoting metabolically dormant mycobacterial persisters.
Oxidative Stress, HIV, and TB: Understanding the Connection
Oxidative stress occurs when there's an imbalance between free radicals (unstable molecules that can damage cells) and antioxidants (which neutralize free radicals) in the body. Both HIV and TB infections can disrupt this balance, leading to elevated levels of oxidative stress. This stress can contribute to immune dysfunction and disease progression.
- Malondialdehyde (MDA): A marker of lipid peroxidation, indicating cell damage from oxidative stress. Higher levels generally suggest greater oxidative stress.
- Catalase (CAT): An enzyme that breaks down hydrogen peroxide into water and oxygen, helping to reduce oxidative damage. Higher levels indicate better antioxidant defense.
- Reduced Glutathione (GSH): A major antioxidant that protects cells from damage. Lower levels suggest reduced antioxidant capacity.
- Superoxide Dismutase (SOD): An enzyme that helps break down superoxide radicals, another type of harmful free radical. Higher levels indicate better antioxidant defense.
Vitamin Supplementation Findings
An integrative review describes a clinical trial involving Nigerian participants with HIV, including people co-infected with tuberculosis, who received vitamin A (5,000 IU) and vitamin C (2,600 mg) for one month to assess oxidative-stress parameters. A separate review reports that oral supplementation with ascorbic acid did not increase antioxidant status in patients with HIV. Another review states that vitamin C supplementation has not shown a positive correlation with reduced oxidative stress.
Evidence and Supplement Considerations
A prospective randomized study examined vitamin A at 5,000 IU and vitamin C at 2,600 mg for their effects on oxidative-stress markers in people with HIV alone and people co-infected with HIV and TB. A review of oxidative stress in people with HIV reports higher oxidative stress without changes in antioxidant levels among HIV-positive smokers and people with substance abuse, and higher oxidative protein products with lower antioxidant levels during long-term versus short-term ART use. NIH HIVinfo provides guidance on potential benefits and risks of dietary supplements for people with HIV, including drug interactions, but the supplied material does not specify the guidance for these particular vitamins.
The Verdict: Do Vitamin A and C Supplements Make a Difference?
The study revealed that vitamin A and C supplementation didn't provide the anticipated benefits in modulating oxidative stress in HIV and HIV/TB co-infected individuals. In fact, in some instances, the vitamins seemed to have a counterproductive effect, potentially exacerbating oxidative stress.
Oxidative Stress and Health Risks
A review describes oxidative stress as an imbalance favoring oxidants over antioxidants and associates it with increased morbidity and mortality in people with HIV receiving ART. It also reports that excess reactive oxygen species can damage mitochondrial DNA and links oxidative stress in people with HIV to cancer, neurodegenerative and cardiovascular diseases, and premature aging. These are associations and risks described in the review; the supplied material does not establish that vitamins A or C prevent them.
Results in HIV and HIV-TB Co-Infection
A study of people with HIV alone and people co-infected with HIV and TB concluded that vitamin A and vitamin C supplementation had no positive modulatory role or benefit on the oxidative-stress indices it assessed. The study used vitamin A at 5,000 IU and vitamin C at 2,600 mg. The supplied source material does not report a demonstrated improvement in these measures from the supplementation.
Specifically, the research indicated that while there were some changes in oxidative stress markers after supplementation, the overall impact wasn't significantly positive. For example, in HIV/TB co-infected subjects, levels of SOD and CAT (both antioxidants) decreased after supplementation, while MDA (a marker of oxidative damage) increased. This suggests that, at the dosages used in the study, the vitamins didn't effectively bolster the antioxidant defense system.
It's crucial to remember that this study provides a snapshot of a specific population and intervention. More research is needed to fully understand the complex interplay between HIV, TB, oxidative stress, and micronutrient supplementation. If you're living with HIV or TB, it's always best to consult with your healthcare provider to determine the most appropriate strategies for supporting your health, rather than self-prescribing supplements.